Implementing Evidenced-Based Treatment Regimens, New Models of Care, and Patient Management Strategies for Multiple Sclerosis — Web Activity

Module 1: Treatment Recommendations and Benefit Design Strategies for MS
0.75 CME credits

Module 2: Implementing a Comprehensive MS Care Model
0.75 CME credits

Release date: February 1, 2015
Expiration date: August 31, 2016
Estimated time to complete activity: 1.5 hours
- Module 1: 0.75 hours
- Module 2: 0.75 hours
Compatible with (IE 6 and up, Firefox, Safari)

DISTINGUISHED FACULTY

Module 1: Treatment Recommendations and Benefit Design Strategies for MS


	Jeffrey D. Dunn, PharmD, MBA Senior Vice President VRx Pharmacy Services, LLC Click here for biography


	Fred D. Lublin, MD, FAAN, FANA Saunders Family Professor of Neurology Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis Icahn School of Medicine at Mount Sinai Click here for biography

Module 2: Implementing a Comprehensive MS Care Model


	Jeffrey D. Dunn, PharmD, MBA Senior Vice President VRx Pharmacy Services, LLC Click here for biography


	Bruce Sherman, MD, FCCP, FACOEM Consulting Corporate Medical Director, Wal-Mart Stores, Inc. Medical Director, Employers Health Coalition Click here for biography

EDUCATIONAL OBJECTIVES

Module 1: Treatment Recommendations and Benefit Design Strategies for MS

After completing this activity, the participant should be better able to:

Review current and emerging clinical data to enhance therapeutic decision-making and optimize outcomes for MS treatments
Evaluate innovative specialty pharmacy benefit models and specialty management services for MS
Provide accurate and appropriate counsel as part of the managed care treatment team
Provide appropriate care and counsel for patients and their families

Module 2: Implementing a Comprehensive MS Care Model

After completing this activity, the participant should be better able to:

Implement the necessary collaborations, processes, and systems that will drive successful MS treatment in a complicated new accountable care ecosystem
Evaluate innovative specialty pharmacy benefit models and specialty management services for MS
Provide accurate and appropriate counsel as part of the managed care treatment team
Provide appropriate care and counsel for patients and their families

TARGET AUDIENCE

Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for patients with multiple sclerosis including: physicians, pharmacists, registered nurses, and case managers

STATEMENT OF NEED/PROGRAM OVERVIEW

There is a documented need to provide the managed care community with insights from notable clinical and managed care experts regarding the treatment of patients with multiple sclerosis (MS) and the evolving role of managed care and specialty pharmacy management. This educational program will include various discussions and interventions, as well as practical demonstrations, regarding current and emerging clinical data, pharmacy benefit design, and management resources for managed care professionals to consider. Neurology and managed care thought leaders will evaluate and recommend innovative strategies that will increase knowledge and competence of the target audience as they strive to improve treatment outcomes for MS patients.

ACCREDITATION

Physician Continuing Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation (both modules)
Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Module 1 – 0.75 CME credits
Module 2 – 0.75 CME credits

Pharmacist Continuing Education

Accreditation Statement


	Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation (both modules)
Postgraduate Institute for Medicine designates these educational activities for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Module 1 – 0.75 contact hours, Universal Activity Number: 0809-9999-15-001-H01-P, (Application)
Module 2 – 0.75 contact hours, Universal Activity Number: 0809-9999-15-026-H01-P, (Knowledge)

Upon completion of the activity evaluation, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

Nursing Continuing Education

Credit Designation (both modules)
These educational activities for 1.4 contact hours are provided by Postgraduate Institute for Medicine.

Module 1 – 0.7 contact hours
Module 2 – 0.7 contact hours

Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A statement of credit will be issued only upon receipt of a completed activity evaluation form.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

*Name of Faculty or Presenter*	*Reported Financial Relationship*
Jeffrey D. Dunn, PharmD, MBA	Consulting Fees: Biogen Idec, Genzyme, a Sanofi company, Teva Pharmaceutical Industries
Fred D. Lublin, MD, FAAN, FANA	Consulting Fees: Acorda Therapeutics, Inc., Actelion, Bayer HealthCare Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Celgene Corporation, Coronado Bioscience, EMD Serono, Inc., Forward Pharma, Genentech, Genzyme, a Sanofi company, Johnson & Johnson, MedImmune, Novartis Pharmaceuticals Corporation, Questcor, Receptos, Revalesio, Roche, Sanofi-Aventis, Teva Neuroscience, to-BBB technologies, Xenoport Research Funding: Acorda Therapeutics, Inc., Biogen Idec, Celgene Corporation, Genzyme, a Sanofi company, National Institute of Health, National Multiple Sclerosis Society, Novartis Pharmaceuticals Corporation, Teva Neuroscience, Transparency Life Sciences Speaker (non-promotional): Genzyme, a Sanofi company Financial Interest: Cognition Pharmaceuticals, Inc.
Bruce W. Sherman, MD, FCCP, FACOEM	Consulting Fees: Humana Inc., Merck & Co., Inc. Fees for Non-CME/CE Services: AbbVie, Eisai Pharmaceuticals, Merck & Co., Inc., Pfizer, Inc. Research Grant: Pfizer, Inc.

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

*Name of Planner or Manager*	*Reported Financial Relationship*
Steven Casebeer, MBA	No financial interest/relationships relating to the topic of this activity
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period February 1, 2015 through August 31, 2016, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, your certificate will be made available immediately to download and print.

For Pharmacists: Upon completion of the activity evaluation, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.